What is SPRC's market cap?

$347.19K, based on the Nov 2 close of $0.60.

Does SciSparc pay a dividend?

No regular cash dividend has been paid in the last year.

How much of SPRC is sold short?

12.1K shares, 2.2% of float, as of Oct 15, 2026.

NASDAQ · SPRC

SciSparc Ltd. Ordinary Shares (SPRC)

$0.5976−11.64%

Close Nov 2, 2026 · split-adjusted

Oct 28, 2026$0.83▼ 97.49% in range

Oct 28, 2025Low $0.83 · High $38.89Oct 28, 2026

What changed · written from our data

As of Nov 2, 2026

SciSparc closed at $0.60 on Nov 2, down 11.64%, within 0.0% of its 52-week closing low. Volume of 225.2K shares was 0.05× its 20-day average (below normal).

Split-adjusted performance: -87.3% over one month, -91.7% over six months, -98.0% over one year.

Short interest was 12.1K shares at the Oct 15 settlement, up 6.6% from the prior report (2.2% of float, 1.0 days to cover).

Market cap$347.2K581.0K shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone

52-week range0.60 – 38.89−98.5% from high

Volume225.2K0.05× 20-day avg

Volatility · 60d171.7%Annualised

Short % of float2.2%1.0 days to cover

Net cash$4.2MCash $4.6M

Next earnings—Not scheduled

Split-adjusted performance

1W −53.7%1M −87.3%3M −91.1%6M −91.7%YTD −95.1%1Y −98.0%3Y −99.9%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short12.1K+6.6% vs prior

Days to cover1.0Settled Oct 15

% of float2.2%

Short vol. 10d43.2%of daily volume

News about SciSparc

All news →

Why Is SciSparc Stock Skyrocketing On Thursday?Benzinga · May 28, 2026▲ Positive SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trailsBenzinga · Mar 10, 2026▲ Positive

Quick answers

What does SciSparc do?: SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field.
What is SPRC's market cap?: $347.19K, based on the Nov 2 close of $0.60.
Does SciSparc pay a dividend?: No regular cash dividend has been paid in the last year.
How much of SPRC is sold short?: 12.1K shares, 2.2% of float, as of Oct 15, 2026.

About SciSparc

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

3 employeesListed Aug 27, 2021scisparc.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology